CEBPZ and acute myeloid leukemia: We also separately evaluated the 177 significant DEPs identified in our comparative analyses described above (CBF-AML vs. non-CBF-AML; MRD1-positive vs. MRD1-negative; and low vs. high Ara-C LC50) for correlation with gene expression levels from matching leukemic cells at diagnosis.